Promotional Labeling and Advertising Considerations for Prescription B fda.govFDA finalizes guidance on biologic, biosimilar promotional labeling Regulatory Affairs Professionals Society | RAPSBiosimilars News Roundup: Approvals Surge Amid Policy Changes Center for BiosimilarsParexel Exec On How CROs Should Prepare For Biosimilar Pathway, AI-Led Changes Citeline News & InsightsFDA’s Drug Price Push in Biosimilar Plan Hinges on Other Reforms Bloomberg Law News